Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-...

Por Paz-Ares, Luis, Moecks, Joachim, Klughammer, Barbara
Publicado em 2011

Necitumumab for first-line treatment of advanced, squamous, non-small-cell lung cancer: a relevant step forward?

Por Zugazagoitia, Jon, Ponce, Santiago, Paz-Ares, Luis
Publicado no Transl Lung Cancer Res (2016)

Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications

Por Quintanal-Villalonga, A., Paz-Ares, Luis, Ferrer, Irene, Molina-Pinelo, S.
Publicado no Dis Markers (2016)

Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Por Robinson, Bruce G., Paz-Ares, Luis, Krebs, Annetta, Vasselli, James, Haddad, Robert
Publicado em 2010

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer

Por Marrugal, Ángela, Ojeda, Laura, Paz-Ares, Luis, Molina-Pinelo, Sonia, Ferrer, Irene
Publicado no Dis Markers (2016)

Pooled analysis of clinical outcome for EGFR TKI-treated patients with EGFR mutation-positive NSCLC

Por Paz-Ares, Luis, Soulières, Denis, Moecks, Joachim, Bara, Ilze, Mok, Tony, Klughammer, Barbara
Publicado em 2014

Non–Small Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy

Por Carbone, David P., Gandara, David R., Antonia, Scott J., Zielinski, Christoph, Paz-Ares, Luis
Publicado no J Thorac Oncol (2015)

Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immedia...

Por Paz-Ares, Luis G, Altug, Sedat, Vaury, Alexandra Thareau, Jaime, Jesús Corral, Russo, Francesca, Visseren-Grul, Carla
Publicado em 2010

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

Por Paz-Ares, Luis, Soulières, Denis, Melezínek, Ivan, Moecks, Joachim, Keil, Lorenz, Mok, Tony, Rosell, Rafael, Klughammer, Barbara
Publicado em 2010

Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib

Por Zugazagoitia, Jon, Díaz, Asunción, Jimenez, Elisabeth, Nuñez, Juan Antonio, Iglesias, Lara, Ponce-Aix, Santiago, Paz-Ares, Luis
Publicado no Front Med (Lausanne) (2017)

Treating KRAS-mutant NSCLC: latest evidence and clinical consequences

Por Garrido, Pilar, Olmedo, María Eugenia, Gómez, Ana, Paz Ares, Luis, López-Ríos, Fernando, Rosa-Rosa, Juan Manuel, Palacios, José
Publicado no Ther Adv Med Oncol (2017)

An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurren...

Por Hellmann, Matthew, Ramalingam, Suresh, Reck, Martin, O'Byrne, Ken, Paz-Ares, Luis, Harbison, Christopher T, Bhagavatheeswaran, Prabhu, Nathan, Faith, Brahmer, Julie
Publicado no J Immunother Cancer (2015)

Association between the miRNA Signatures in Plasma and Bronchoalveolar Fluid in Respiratory Pathologies

Por Molina-Pinelo, Sonia, Suárez, Rocío, Pastor, María Dolores, Nogal, Ana, Márquez-Martín, Eduardo, Martín-Juan, José, Carnero, Amancio, Paz-Ares, Luis
Publicado em 2012

A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry

Por Angulo, Bárbara, Conde, Esther, Suárez-Gauthier, Ana, Plaza, Carlos, Martínez, Rebeca, Redondo, Pilar, Izquierdo, Elisa, Rubio-Viqueira, Belén, Paz-Ares, Luis, Hidalgo, Manuel, López-Ríos, Fernando
Publicado em 2012

PARAMOUNT: Descriptive Subgroup Analyses of Final Overall Survival for the Phase III Study of Maintenance Pemetrexed versus Placebo Following Induction Treatment with Pemetrexed Pl...

Por Reck, Martin, Paz-Ares, Luis G., de Marinis, Filippo, Molinier, Olivier, Sahoo, Tarini Prasad, Laack, Eckart, John, William, Zimmermann, Annamaria H., Visseren-Grul, Carla, Gridelli, Cesare
Publicado em 2014

Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma

Por Schöffski, Patrick, Guillem, Vincente, Garcia, Margarita, Rivera, Fernando, Tabernero, Josep, Cullell, Martin, Lopez-Martin, Jose Antonio, Pollard, Patricia, Dumez, Herlinde, del Muro, Xavier Garcia, Paz-Ares, Luis
Publicado em 2009

Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer

Por Estevez-Garcia, Purificacion, Rivera, Fernando, Molina-Pinelo, Sonia, Benavent, Marta, Gómez, Javier, Limón, Maria Luisa, Pastor, Maria Dolores, Martinez-Perez, Julia, Paz-Ares, Luis, Carnero, Amancio, Garcia-Carbonero, Rocio
Publicado no Oncotarget (2015)

Identification of Oxidative Stress Related Proteins as Biomarkers for Lung Cancer and Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage

Por Pastor, Maria Dolores, Nogal, Ana, Molina-Pinelo, Sonia, Meléndez, Ricardo, Romero-Romero, Beatriz, Mediano, Maria Dolores, López-Campos, Jose L., García-Carbonero, Rocío, Sanchez-Gastaldo, Amparo, Carnero, Amancio, Paz-Ares, Luis
Publicado em 2013

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers

Por Usó, Marta, Jantus-Lewintre, Eloisa, Bremnes, Roy M., Calabuig, Silvia, Blasco, Ana, Pastor, Enrique, Borreda, Irene, Molina-Pinelo, Sonia, Paz-Ares, Luis, Guijarro, Ricardo, Martorell, Miguel, Forteza, Jerónimo, Camps, Carlos, Sirera, Rafael
Publicado no Oncotarget (2016)

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Por Garcia-Carbonero, Rocio, Salazar, Ramon, Duran, Ignacio, Osman-Garcia, Ignacio, Paz-Ares, Luis, Bozada, Juan M., Boni, Valentina, Blanc, Christine, Seymour, Len, Beadle, John, Alvis, Simon, Champion, Brian, Calvo, Emiliano, Fisher, Kerry
Publicado no J Immunother Cancer (2017)